XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Note 11 - Stock Option Plan
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
1
1
— STOCK OPTION PLAN
 
The Company currently has
two
equity based incentive plans, the Oak Valley Bancorp
2008
Stock Plan and the Oak Valley Bancorp
2018
Stock Plan. The
2018
Stock Plan provides for awards in the form of incentive stocks, non-statutory stock options, stock appreciation rights and restrictive stocks. Under the
2018
Plan, the Company is authorized to issue
607,500
shares of its common stock to key employees and directors as incentive and non-qualified stock options, respectively, at a price equal to the fair value on the date of grant. The Plan provides that the options are exercisable in equal increments over a
five
-year period from the date of grant or over any other schedule approved by the Board of Directors. All incentive stock options expire
no
later than
ten
 years from the date of grant. Future grants are
not
permitted under the
2008
Stock Plan and will all be issued from the
2018
Stock Plan until it expires. As of
December 31, 2018,
595,250
shares were available to be issued under the
2018
Stock Plan pursuant to new grants.
 
A summary of the status of the Company’s stock option plan and changes during the years end
December 31, 2018
and
2017
are presented below.
 
 
   
DECEMBER 31, 201
8
   
DECEMBER 31, 201
7
 
   
Shares
   
Weighted-
Average
Exercise Price
   
Shares
   
Weighted-
Average
Exercise Price
 
Outstanding at beginning of year
   
3,500
    $
5.94
     
15,000
    $
9.58
 
Granted
   
0
    $
0.00
     
0
    $
0.00
 
Exercised
   
(1,500
)
  $
4.58
     
(9,000
)
  $
10.10
 
Forfeited
   
(1,000
)
  $
8.25
     
(2,500
)
  $
12.75
 
Outstanding at end of year
   
1,000
    $
5.74
     
3,500
    $
5.94
 
 
(dollars in thousands)
 
December 31,
 
   
201
8
   
201
7
 
Weighted-average fair value of options granted during the year
   
N/A
     
N/A
 
                 
Intrinsic value of options exercised
  $
20
    $
56
 
                 
Options outstanding and exercisable at year end:
   
1,000
     
3,500
 
Weighted average exercise price
  $
5.74
    $
5.94
 
Intrinsic value
  $
13
    $
48
 
Weighted average remaining contractual life (in months)
   
1
     
9
 
 
 
For the year ended
December 
31,
2018
and
2017,
there was
no
recorded income tax benefits related to disqualifying dispositions of stock option exercises. All outstanding stock options became fully vested during
2014
and therefore there is
no
remaining unrecognized stock option compensation expense.
 
A summary of the status of the Company’s restricted stock and changes during the years ended
December 31, 2018
and
2017
are presented below.
 
 
   
DECEMBER 31, 2018
   
DECEMBER 31, 2017
 
   
Shares
   
Weighted
Average
Grant Date
Fair Value
   
Shares
   
Weighted
Average
Grant Date
Fair Value
 
Unvested at beginning of year
   
24,800
    $
11.07
     
56,075
    $
8.16
 
Granted
   
96,650
    $
21.40
     
8,000
    $
14.62
 
Vested
   
(11,900
)
  $
11.93
     
(32,425
)
  $
7.45
 
Cancelled
   
(1,950
)
  $
20.21
     
(6,850
)
  $
8.54
 
Unvested at end of year
   
107,600
    $
20.09
     
24,800
    $
11.07
 
 
 
The Company granted
96,650
shares of restricted stock in
2018
with a weighted average fair value of
$21.40
per share. For the year ended
December 31, 2018,
total compensation expense recorded in the consolidated statements of income related to restricted stock awards was
$431,000,
with an offsetting tax benefit of
$128,000,
as this expense is deductible for income tax purposes. The Company recorded an additional tax benefit of
$22,000
to income tax expense to recognize the full tax deduction of the vested restricted stock, which is equal to the fair value on the vesting date, as the tax benefit from the restricted stock expense is based on the grant date fair value. As of
December 
31,
2018,
there was
$1,813,000
of total unrecognized compensation cost related to restricted stock awards which is expected to be recognized over a weighted-average period of
4.14
years. During
2018,
shares of restricted stock awards totaling
11,900
with a fair value of
$252,000,
based on the vested date of each award, were vested and became unrestricted.
 
The Company granted
8,000
shares of restricted stock in
2017
with a weighted average fair value of
$14.62
per share. For the year ended
December 31, 2017,
total compensation expense recorded in the consolidated statements of income related to restricted stock awards was
$103,000,
with an offsetting tax benefit of
$42,000,
as this expense is deductible for income tax purposes. The Company recorded an additional tax benefit of
$88,000
to income tax expense to recognize the full tax deduction of the vested restricted stock, which is equal to the fair value on the vesting date, as the tax benefit from the restricted stock expense is based on the grant date fair value. As of
December 
31,
2017,
there was
$216,000
of total unrecognized compensation cost related to restricted stock awards which is expected to be recognized over a weighted-average period of
3.46
years. During
2017,
shares of restricted stock awards totaling
32,425
with a fair value of
$241,000,
based on the vested date of each award, were vested and became unrestricted.